PS(18:3/20:4)
|
Basic information |
| Metabolite name | PS(18:3/20:4) |
 | N/A |
 |
C02737 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PS(18:3/20:4) |
| N/A |
|
C02737 |
|
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between PS(18:3/20:4) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M781 | Type2 | post-escitalopram treatment vs. baseline, MDD group | Plasma | Human | Down |
| Study M835 | Type1 | CRS group vs. control group | Faece | C57BL/6 mouse | Up |